{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF05773",
      "entity_text" : "RWD",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01060",
      "entity_text" : "patients.1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The 21st Century Cures Act of 2016 provided a framework to the US Food and Drug Administration (FDA) to rapidly move treatments to patients.1 The increased acceptability of real-world data (RWD) sources allows for innovative ways to study products and has the potential to reduce trial costs.",
  "reading_complete" : "2020-08-05T21:54:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T21:53:59Z",
  "trigger" : "acceptability",
  "evidence" : [ "patients.1 The increased acceptability of real-world data (RWD" ],
  "pmc_id" : "6718007",
  "score" : 0
}